288
Views
20
CrossRef citations to date
0
Altmetric
Case Reports

Acute fulminant hepatitis E virus genotype 3e infection: Description of the first case in Europe

, , , , , , , , & show all
Pages 727-731 | Received 22 Apr 2014, Accepted 19 May 2014, Published online: 19 Aug 2014

References

  • Pérez-Gracia MT, Suay B, Mateos-Lindemann ML. Hepatitis E: an emerging disease. Infect Genet Evol 2014; 13:40–59.
  • Acharya SK, Panda SK. Hepatitis E: water, water everywhere—now a global disease. J Hepatol 2011;54:9–11.
  • Suzuki K, Aikawa T, Okamoto H. Fulminant hepatitis E in Japan. N Engl J Med 2002;347:1456.
  • Ijaz S, Arnold E, Banks M, Bendall RP, Cramp ME, Cunningham R, et al. Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis 2005;192: 1166–72.
  • Dalton HR, Hazeldine S, Banks M, Ijaz S, Bendall R. Locally acquired hepatitis E in chronic liver disease. Lancet 2007;369:1260.
  • Inoue J, Ueno Y, Nagasaki F, Akahane T, Fukushima K, Kogure T, et al. Sporadic acute hepatitis E occurred constantly during the last decade in northeast Japan. J Gastroenterol 2009;44:329–37.
  • Romanò L, Paladini S, Tagliacarne C, Canuti M, Bianchi S, Zanetti AR. Hepatitis E in Italy: a long-term prospective study. J Hepatol 2011;54:34–40.
  • Peron JM, Dalton H, Izopet J, Kamar N. Acute autochthonous hepatitis E in Western patients with underlying chronic liver disease: a role for ribavirin? J Hepatol 2011; 54:1323–4.
  • Garbuglia AR, Scognamiglio P, Petrosillo N, Mastroianni CM, Sordillo P, Gentile D, et al. Hepatitis E virus genotype 4 outbreak, Italy, 2011. Emerg Infect Dis 2013;19:110–4.
  • Nakano T, Okano H, Kobayashi M, Ito K, Ohmori S, Nomura T, et al. Molecular epidemiology and genetic history of European-type genotype 3 hepatitis E virus indigenized in the central region of Japan. Infect Genet Evol 2012;12:1524–34.
  • La Rosa G, Muscillo M, Vennarucci VS, Garbuglia AR, La Scala P, Capobianchi MR. Hepatitis E virus in Italy: molecular analysis of travel-related and autochthonous cases. J Gen Virol 2011;92:1617–26.
  • Kumar AS, Kumar SP, Singh R, Kumar MS, Madan K, Kumar JJ, et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol 2007;46:387–94.
  • Haïm-Boukobza S, Ferey MP, Vétillard AL, Jeblaoui A, Pélissier E, Pelletier G, et al. Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. J Hepatol 2012;57:1374–8.
  • Doudier B, Vencatassin H, Aherfi S, Colson P. Fatal fulminant hepatitis E associated with autoimmune hepatitis and excessive paracetamol intake in southeastern France. J Clin Microbiol 2014;52:1294–7.
  • Nakano T, Takahashi K, Arai M, Okano H, Kato H, Ayada M, et al. Identification of European-type hepatitis E virus subtype 3e isolates in Japanese wild boars: molecular tracing of HEV from swine to wild boars. Infect Genet Evol 2013;18:287–98.
  • Colson P, Borentain P, Queyriaux B, Kaba M, Moal V, Gallian P, et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010;202: 825–34.
  • Abbas Z, Afzal R. Hepatitis E: when to treat and how to treat. Antivir Ther 2014;19:125–31.
  • Kamar N, Rostaing L, Abravanel F, Garrouste C, Lhomme S, Esposito L, et al. Ribavirin therapy inhibits viral replication in patients with chronic hepatitis E virus infection. Gastroenterology 2010;139:1612–8.
  • Gerolami R, Borentain P, Raissouni F, Motte A, Solas C, Colson P. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol 2011;52:60–2.
  • Goyal R, Kumar A, Panda SK, Paul SB, Acharya SK. Ribavirin therapy for hepatitis E virus-induced acute-on-chronic liver failure: a preliminary report. Antivir Ther 2012;17:1091–6.
  • Pischke S, Hardtke S, Bode U, Birkner U, Chatzikyrkou C, Kauffmann, et al. Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience. Liver Int 2013; 33:722–6.
  • Debing Y, Emerson SU, Wang Y, Pan Q, Balzarini J, Dallmeier K, et al. Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interpheron. Antimicrob Agents Chemother 2014;58:267–73.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.